McKenzie J M
Rheumatol Rehabil. 1977 May;16(2):78-82. doi: 10.1093/rheumatology/16.2.78.
A double-blind clinical trial on 60 patients with rheumatoid disease comparing 10 mg sodium aurothiomalate weekly to 50 mg weekly is continuing. An initial report on thirty of these patients, who had completed a year of treatment, shows no statistically significant difference in the response between the two groups. No conclusions can be drawn about toxic reactions in this number of patients having received treatment for only one year.
一项针对60名类风湿疾病患者的双盲临床试验正在进行，该试验比较了每周注射10毫克金硫代苹果酸钠与每周注射50毫克金硫代苹果酸钠的效果。一份关于其中30名已完成一年治疗的患者的初步报告显示，两组之间的反应在统计学上没有显著差异。对于仅接受了一年治疗的这些患者的毒性反应，目前还无法得出结论。
